ISCT22: Tackling the ethical issues around cell and gene therapy


May 5, 2022 -- Unproven and unethical cell and gene therapies (CGTs) are a growing problem worldwide, according to Laertis Ikonomou, PhD, associate professor in the Department of Oral Biology at the University of Buffalo, and chair of the International Society for Cell & Gene Therapy (ISCT) Committee on the Ethics of Cell and Gene Therapy.

Ikonomou spoke with ScienceBoard.net about the ethical and regulatory issues around the rapid growth of the global CGT industry, as the ISCT 2022 annual meeting kicked off in San Francisco this week.

The ISCT Committee on the Ethics of Cell and Gene Therapy is composed of international experts charged with examining unproven and unethical CGT interventions and promoting safe and effective practices around the world. Ikonomou describes it as a "borderless" direct-to-consumer problem in many countries.

For example, in the U.S. during the COVID-19 pandemic, Ikonomou said direct-to-consumer businesses have made unsubstantiated and inaccurate claims about purported "stem cell" products for the coronavirus. Researchers have called for stronger regulations to deter the sale of unproven cell-based products, and more responsible and accurate science communication.

Watch the video below to learn more.



Copyright © 2022 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here